All material subject to strictly enforced copyright laws. © 2022 Euromoney Institutional Investor PLC group
Syndicated Loans

Suitors for Pfizer's consumer healthcare unit vanish

Pfizer

Pfizer’s consumer healthcare business has gone from being the belle of the ball to the last one left on the dancefloor on Friday, after GlaxoSmithKline joined Reckitt Benckiser in pulling out of a potential acquisition of the unit.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree